Contribution: Industrial Research Assistance Program – Contributions to Firms
TinyEYE Technologies Corporation
$320,000.00
Advancing Therapy Technology for Scalability, Efficiency, and Differentiation.
FY 2018-19 · 2018-06-17
Summary
Online therapy is breaking into the early majority. This project aims to develop a suite of new online therapy technologies aimed at scaling TinyEYE’s technical platform to serve 10X its current user base, to improve service efficiency by 20%, and to differentiate from both traditional therapy and emerging competition.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Saskatoon|Saskatoon, Saskatchewan, Canada
Recipient Type
For-profit organization
Business Number
831850946
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2019-08-31
Agreement Number
909124
Agreement Start Date
2018-06-17
Agreement Title
Advancing Therapy Technology for Scalability, Efficiency, and Differentiation.
Agreement Title (French)
Faire progresser la technologie de traitement pour l’extensibilité, l’efficience et la différenciation
Agreement Type
Contribution
Agreement Value
$320,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Online therapy is breaking into the early majority. This project aims to develop a suite of new online therapy technologies aimed at scaling TinyEYE’s technical platform to serve 10X its current user base, to improve service efficiency by 20%, and to differentiate from both traditional therapy and emerging competition.
Description (French)
La thérapie en ligne est par effraction dans le début de la majorité. Ce projet vise à développer un ensemble de nouvelles technologies de traitement en ligne visant à l’échelle la plateforme technique TinyEYE pour desservir 10X son nombre d'utilisateurs actuels, pour améliorer l'efficacité du service de 20 %, et à distinguer les deux thérapies traditionnelles et la compétition émergente.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Saskatoon--University
Federal Riding (French)
Saskatoon--University
Federal Riding Number
47011
NAICS Code
519130
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
831850946
Recipient City
Saskatoon|Saskatoon
Recipient Country
CA
Recipient Legal Name
TinyEYE Technologies Corporation
Recipient Postal Code
S7N 3R3
Recipient Province or Territory
SK
Recipient Type
F
Reference Number
172-2018-2019-Q2-909124
